The Belgian Supreme Court construes the rules for descriptive seizures in a patent infringement case between Novartis and GSK.

In its decision of 24 March 2011, the Supreme Court ruled that a party that is involved in descriptive seizure proceedings is entitled at any stage of the proceedings to ask that confidential information which is not directly related to the alleged infringement of an intellectual property right is not disclosed to the plaintiff.